LORI RULE: Open Payments
NPI 1073596433 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,061 in 198 payments from 20 companies in 2025. Trend: 2023 $2,445 · 2024 $2,751 · 2025 $3,061
Food & beverage: $2,954Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $485 |
| Janssen Biotech, Inc. | 15 | $280 |
| Novartis Pharmaceuticals Corporation | 17 | $268 |
| Regeneron Healthcare Solutions, Inc. | 11 | $251 |
| E.R. Squibb & Sons, L.L.C. | 12 | $226 |
| Lilly USA, LLC | 12 | $200 |
| Galderma Laboratories, L.P. | 16 | $185 |
| UCB, Inc. | 17 | $183 |
| Arcutis Biotherapeutics, Inc. | 20 | $181 |
| LEO Pharma Inc. | 14 | $170 |
Products named: DUPIXENT, RINVOQ, TREMFYA, Sotyktu, COSENTYX, SKYRIZI, TALTZ, Bimzelx.
Industry payments across OK — which companies pay providers there.
